Advantage Alpha Capital Partners LP Dynavax Technologies Corp Transaction History
Advantage Alpha Capital Partners LP
- $515 Million
- Q1 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 88,683 shares of DVAX stock, worth $982,607. This represents 0.21% of its overall portfolio holdings.
Number of Shares
88,683
Previous 89,087
0.45%
Holding current value
$982,607
Previous $1.25 Million
11.65%
% of portfolio
0.21%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
269Shares Held
132MCall Options Held
326KPut Options Held
758K-
Black Rock Inc. New York, NY23.2MShares$257 Million0.01% of portfolio
-
State Street Corp Boston, MA10.6MShares$118 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$104 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.14MShares$101 Million3.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.99MShares$88.5 Million0.23% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...